citrulline has been researched along with Non-alcoholic Fatty Liver Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gopko, OF; Lymanets, TV; Maslova, GS; Skrypnyk, IМ; Skrypnyk, RІ | 1 |
Baumann, A; Bergheim, I; Brandt, A; Camarinha-Silva, A; Hernández-Arriaga, A; Jin, CJ; Jung, F; Nier, A; Rajcic, D; Sánchez, V | 1 |
Maslova, GS; Skrypnyk, IN; Skrypnyk, RІ | 1 |
De Bandt, JP; Jegatheesan, P; M'bouyou-Boungou, J; Nakib, S; Nubret, E; Ouelaa, W; Vicente, C | 1 |
Agah, S; Darabi, Z; Darand, M; Faghihi, A; Hedayati, M; Hekmatdoost, A; Yari, Z | 1 |
Bergheim, I; Beutheu, S; Cynober, L; De-Bandt, JP; Jegatheesan, P; Kapel, N; Nubret, E; Sarfati, G; Ventura, G; Waligora-Dupriet, AJ | 1 |
Bergheim, I; Beutheu, S; De Bandt, JP; Jegatheesan, P; Nubret, E; Sarfati, G; Ventura, G | 1 |
Bergheim, I; Beutheu, S; Butel, MJ; De Bandt, JP; Freese, K; Jegatheesan, P; Nubret, E; Waligora-Dupriet, AJ | 1 |
Bergheim, I; De Bandt, JP; Engstler, AJ; Jin, CJ; Sellmann, C | 1 |
1 trial(s) available for citrulline and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial.
Topics: Alanine Transaminase; C-Reactive Protein; Citrulline; Dietary Supplements; Double-Blind Method; Humans; Inflammation; NF-kappa B; Non-alcoholic Fatty Liver Disease; Outcome Assessment, Health Care; Tumor Necrosis Factor-alpha | 2019 |
8 other study(ies) available for citrulline and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Arginine/citrulline cycle changes in diet-induced rat model of non-alcoholic fatty liver disease.
Topics: Animals; Arginine; Citrulline; Diet; Female; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley | 2020 |
Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase.
Topics: Animals; Arginase; Citrulline; Diet, High-Fat; Dietary Supplements; Female; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Toll-Like Receptor 4 | 2021 |
THE EFFECT OF DOXORUBICIN-INDUCED OXIDATIVE STRESS ON CITRULLINE CONCENTRATION IN THE SMALL INTESTINAL MUCOSA AND PLASMA BLOOD IN RATS WITH NON-ALCOHOLIC STEATOHEPATITIS.
Topics: Citrulline; Doxorubicin; Female; Humans; Intestinal Mucosa; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress | 2021 |
Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Citrulline; Dietary Supplements; Dyslipidemias; Fructose; Inflammation; Insulin Resistance; Lipopolysaccharides; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats, Sprague-Dawley; Toll-Like Receptor 4 | 2017 |
Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Arginine; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Cholesterol; Citrulline; Dietary Supplements; Fructose; Glutamine; Hypertriglyceridemia; Insulin; Insulin Resistance; Intestinal Absorption; Lipid Metabolism; Liver; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; RNA, Messenger; Toll-Like Receptor 4; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats.
Topics: Algorithms; Amino Acids; Animals; Arginine; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Biomarkers; Citrulline; Dietary Supplements; Fatty Acid Synthase, Type I; Fructose; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Humans; Insulin Resistance; Liver; Male; Non-alcoholic Fatty Liver Disease; Ornithine; PPAR alpha; Random Allocation; Rats, Sprague-Dawley; Sterol Regulatory Element Binding Protein 1 | 2015 |
Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bacteroides; Citrulline; Claudin-1; Colon; Diet, Western; Endoplasmic Reticulum Stress; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Lipid Droplets; Liver; Male; Non-alcoholic Fatty Liver Disease; Prevotella; Rats, Sprague-Dawley; RNA, Messenger; Toll-Like Receptor 4; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Body Weight; Citrulline; Diet, Western; Dietary Supplements; Disease Models, Animal; Duodenum; Endotoxins; Female; Insulin; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Occludin; Plasminogen Activator Inhibitor 1; Protective Agents; Tight Junction Proteins; Toll-Like Receptor 4; Triglycerides; Zonula Occludens-1 Protein | 2017 |